Innovative Medicines Initiative
Company Description
The Innovative Medicines Initiative (IMI) is Europe's largest public-private initiative aiming to speed up the development of better and safer medicines for patients.
IMI supports collaborative research projects and builds networks of industrial and academic experts in order to boost pharmaceutical innovation in Europe.
IMI is a joint undertaking between the European Union and the pharmaceutical industry association EFPIA.
To know more, please visit www.imi.europa.eu.
Job of the week
EURACTIV News
- French Greens’ top candidate not for ‘giving up hope’ in EU elections race
- Commission mulls weakening petland protection requirement for farmers
- Eurozone emerges from recession but France, Germany stay weak
- Showing courageous responsibility for our Europe
- The shadow play of legitimacy in Sudan’s civil war
Agenda
18 Nov 2024
21 Oct 2024
15 Oct 2024
25 Jun 2024
17 Jun 2024
Subscribe to our jobletter!